Untreated Depression Among Persons Living with Human Immunodeficiency Virus in Kazakhstan: A Cross-sectional Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2018 Mar 29

PMID 29590151

Citations 4

Authors

Dina Terloyeva

Zhamilya Nugmanova

Gulzhakhan Akhmetova

Aikan Akanov

Nimish Patel

Victoria Lazariu

Lisa Norelli

Louise-Anne McNutt

Affiliations

Soon will be listed here.

Abstract

Background: In Kazakhstan, scarce official prevalence data exists for mood disorders. This study investigates the occurrence of depressive symptoms among people living with HIV/AIDS (PLWHA), and the relationship between depressive symptoms, HIV treatment initiation and antiretroviral treatment (ART) adherence.

Methods: A cross-sectional study was conducted among patients seen at the Almaty AIDS Center between April and December 2013. Two data sources were used: 1) self-administered survey that included the Patient Health Questionnaire (PHQ-9) to capture depression symptoms and 2) medical record review. Two primary outcomes were evaluated with log-binomial models and Fisher's exact test: the relationship between depression symptoms and 1) HIV treatment group, and 2) HIV adherence.

Results: Of the 564 participants, 9.9% reported symptoms consistent with a depressive disorder. None had received treatment for depression. Among those not on ART, a relationship between depressive symptoms and low CD4 counts (≤ 350 cells/mm3) was evident (7.1% for CD4 ≤ 350 cells/mm3 vs. 0.9% for CD4 > 350 cells/mm3, p = 0.029). In multivariable analysis, a higher prevalence of depressive symptoms was statistically associated with ART treatment, positive hepatitis C virus (HCV) status, and being unmarried. For those taking ART, treatment adherence was not statistically associated with a lower prevalence of depressive symptoms (12.5% vs 20.0%, p = 0.176); limited power may have impacted statistical significance.

Conclusions: Untreated depression was found among PLWHA suggesting the need to evaluate access to psychiatric treatment. A collaborative strategy may be helpful to optimize HIV treatment outcomes.

Citing Articles

Integrating HIV and mental health interventions to address a global syndemic among men who have sex with men.

Operario D, Sun S, Bermudez A, Masa R, Shangani S, van der Elst E Lancet HIV. 2022; 9(8):e574-e584.

PMID: 35750058 PMC: 7613577. DOI: 10.1016/S2352-3018(22)00076-5.

Global Systematic Review of Common Mental Health Disorders in Adults Living with HIV.

Hoare J, Sevenoaks T, Mtukushe B, Williams T, Heany S, Phillips N Curr HIV/AIDS Rep. 2021; 18(6):569-580.

PMID: 34792706 PMC: 8600343. DOI: 10.1007/s11904-021-00583-w.

Depression and associated factors among HIV-positive youths attending antiretroviral therapy clinics in Jimma town, southwest Ethiopia.

Girma D, Assegid S, Gezahegn Y PLoS One. 2021; 16(1):e0244879.

PMID: 33406163 PMC: 7787463. DOI: 10.1371/journal.pone.0244879.

The Cost Effectiveness of Mental Health Treatment in the Lifetime of Older Adults with HIV in New York City: A Markov Approach.

DelaCruz J, Brennan-Ing M, Kakolyris A, Martinez O Pharmacoecon Open. 2020; 5(2):221-236.

PMID: 33165825 PMC: 7649900. DOI: 10.1007/s41669-020-00238-3.

References

Marwick K, Kaaya S . Prevalence of depression and anxiety disorders in HIV-positive outpatients in rural Tanzania. AIDS Care. 2010; 22(4):415-9. DOI: 10.1080/09540120903253981. View

Kroenke K, Spitzer R, Williams J . The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9):606-13. PMC: 1495268. DOI: 10.1046/j.1525-1497.2001.016009606.x. View

Sledjeski E, Delahanty D, Bogart L . Incidence and impact of posttraumatic stress disorder and comorbid depression on adherence to HAART and CD4+ counts in people living with HIV. AIDS Patient Care STDS. 2005; 19(11):728-36. DOI: 10.1089/apc.2005.19.728. View

Kessler R, Berglund P, Demler O, Jin R, Merikangas K, Walters E . Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6):593-602. DOI: 10.1001/archpsyc.62.6.593. View

Kessler R, McGonagle K, Swartz M, Blazer D, Nelson C . Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J Affect Disord. 1993; 29(2-3):85-96. DOI: 10.1016/0165-0327(93)90026-g. View

Catz S, Kelly J, Bogart L, Benotsch E, McAuliffe T . Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000; 19(2):124-33. View

Nallusamy V, Afgarshe M, Shlosser H . Reliability and validity of Somali version of the PHQ-9 in primary care practice. Int J Psychiatry Med. 2017; 51(6):508-520. DOI: 10.1177/0091217417696732. View

Vrublevska J, Trapencieris M, Rancans E . Adaptation and validation of the Patient Health Questionnaire-9 to evaluate major depression in a primary care sample in Latvia. Nord J Psychiatry. 2017; 72(2):112-118. DOI: 10.1080/08039488.2017.1397191. View

Alpizar D, Lagana L, Plunkett S, French B . Evaluating the eight-item Patient Health Questionnaire's psychometric properties with Mexican and Central American descent university students. Psychol Assess. 2017; 30(6):719-728. PMC: 7591264. DOI: 10.1037/pas0000521. View

10.

Tegger M, Crane H, Tapia K, Uldall K, Holte S, Kitahata M . The effect of mental illness, substance use, and treatment for depression on the initiation of highly active antiretroviral therapy among HIV-infected individuals. AIDS Patient Care STDS. 2008; 22(3):233-43. DOI: 10.1089/apc.2007.0092. View

11.

Kessler R, Chiu W, Demler O, Merikangas K, Walters E . Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005; 62(6):617-27. PMC: 2847357. DOI: 10.1001/archpsyc.62.6.617. View

12.

Ciesla J, Roberts J . Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry. 2001; 158(5):725-30. DOI: 10.1176/appi.ajp.158.5.725. View

13.

Costa J, Torres T, Coelho L, Luz P . Adherence to antiretroviral therapy for HIV/AIDS in Latin America and the Caribbean: Systematic review and meta-analysis. J Int AIDS Soc. 2018; 21(1). PMC: 5810329. DOI: 10.1002/jia2.25066. View

14.

Bernard C, Dabis F, de Rekeneire N . Prevalence and factors associated with depression in people living with HIV in sub-Saharan Africa: A systematic review and meta-analysis. PLoS One. 2017; 12(8):e0181960. PMC: 5544236. DOI: 10.1371/journal.pone.0181960. View

15.

Kaharuza F, Bunnell R, Moss S, Purcell D, Bikaako-Kajura W, Wamai N . Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav. 2006; 10(4 Suppl):S105-11. DOI: 10.1007/s10461-006-9142-2. View

16.

Vranceanu A, Safren S, Lu M, Coady W, Skolnik P, Rogers W . The relationship of post-traumatic stress disorder and depression to antiretroviral medication adherence in persons with HIV. AIDS Patient Care STDS. 2008; 22(4):313-21. DOI: 10.1089/apc.2007.0069. View

17.

Angst J, Gamma A, Gastpar M, Lepine J, Mendlewicz J, Tylee A . Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies. Eur Arch Psychiatry Clin Neurosci. 2002; 252(5):201-9. DOI: 10.1007/s00406-002-0381-6. View

18.

Bing E, Burnam M, Longshore D, Fleishman J, Sherbourne C, London A . Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001; 58(8):721-8. DOI: 10.1001/archpsyc.58.8.721. View

19.

Martin A, Rief W, Klaiberg A, Braehler E . Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population. Gen Hosp Psychiatry. 2005; 28(1):71-7. DOI: 10.1016/j.genhosppsych.2005.07.003. View

20.

Ironson G, OCleirigh C, Fletcher M, Laurenceau J, Balbin E, Klimas N . Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment. Psychosom Med. 2005; 67(6):1013-21. PMC: 2614887. DOI: 10.1097/01.psy.0000188569.58998.c8. View